167 related articles for article (PubMed ID: 8262829)
1. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer.
Kumar MU; Swamy K; Supe SS; Anantha N
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829
[TBL] [Abstract][Full Text] [Related]
2. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
Okawa T; Dokiya T; Nishio M; Hishikawa Y; Morita K
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):623-8. PubMed ID: 10524414
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation.
Nishimura Y; Ono K; Tsutsui K; Oya N; Okajima K; Hiraoka M; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1099-105. PubMed ID: 7961017
[TBL] [Abstract][Full Text] [Related]
4. Results of external irradiation and low-dose-rate intraluminal brachytherapy for esophageal cancer.
Someya M; Sakata K; Saito A; Nagakura H; Oouchi A; Hareyama M
Acta Oncol; 2002; 41(1):63-8. PubMed ID: 11990521
[TBL] [Abstract][Full Text] [Related]
5. Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer.
Akagi Y; Hirokawa Y; Kagemoto M; Matsuura K; Ito A; Fujita K; Kenjo M; Kiriu H; Ito K
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):525-30. PubMed ID: 10078632
[TBL] [Abstract][Full Text] [Related]
6. [The dose of radiotherapy in esophageal cancer combined with external beams and intracavitary radium brachytherapy].
Nishio M; Sakurai T; Kagami Y; Narimatsu N; Ibayashi J; Hareyama M
Gan No Rinsho; 1987 Mar; 33(3):242-8. PubMed ID: 3586340
[TBL] [Abstract][Full Text] [Related]
7. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
Sur RK; Donde B; Levin VC; Mannell A
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
[TBL] [Abstract][Full Text] [Related]
8. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine.
Hishikawa Y; Kurisu K; Taniguchi M; Kamikonya N; Miura T
Radiother Oncol; 1991 Jun; 21(2):107-14. PubMed ID: 1714082
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.
Yorozu A; Dokiya T; Oki Y
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):271-5. PubMed ID: 10487545
[TBL] [Abstract][Full Text] [Related]
10. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study.
Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950
[TBL] [Abstract][Full Text] [Related]
12. Intraluminal high dose rate brachytherapy combined with external radiotherapy in the treatment of oesophageal cancer.
Barone D; Coccia G; Marziano C; Tricerri R; Bonelli L; Tomassini E; Bistolfi F
Panminerva Med; 1993 Jun; 35(2):86-92. PubMed ID: 8414629
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645
[TBL] [Abstract][Full Text] [Related]
14. Radical radiotherapy incorporating a brachytherapy boost for the treatment of carcinoma of the thoracic oesophagus: results from a cohort of patients and review of the literature.
Churn M; Jones B; Myint AS
Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):117-22. PubMed ID: 12069118
[TBL] [Abstract][Full Text] [Related]
15. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone.
Ishikawa H; Sakurai H; Yamakawa M; Saito Y; Nakayama Y; Kitamoto Y; Okamoto M; Harada K; Hasegawa M; Nakano T
J Clin Gastroenterol; 2005 Jul; 39(6):495-500. PubMed ID: 15942435
[TBL] [Abstract][Full Text] [Related]
17. High dose rate brachytherapy for superficial cancer of the esophagus.
Maingon P; d'Hombres A; Truc G; Barillot I; Michiels C; Bedenne L; Horiot JC
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):71-6. PubMed ID: 10656375
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for the esophageal carcinoma: external irradiation versus high-dose rate intraluminal irradiation.
Chatani M; Matayoshi Y; Masaki N
Strahlenther Onkol; 1992 Jun; 168(6):328-32. PubMed ID: 1621210
[TBL] [Abstract][Full Text] [Related]
19. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma.
Muijs CT; Beukema JC; Mul VE; Plukker JT; Sijtsema NM; Langendijk JA
Radiother Oncol; 2012 Feb; 102(2):303-8. PubMed ID: 21885139
[TBL] [Abstract][Full Text] [Related]
20. Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.
Wong Hee Kam S; Rivera S; Hennequin C; Lourenço N; Chirica M; Munoz-Bongrand N; Gornet JM; Quéro L
Brachytherapy; 2015; 14(4):531-6. PubMed ID: 25906950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
